date:Aug 16, 2012
world, Matcon has a global customer base with a strong emphasis on the fast growing food and pharmaceutical markets in Asia. With annual revenues of approximately 22m, Matcon will operate within IDEX's Health and Science Technologies segment in the Materials Processing Technologies platform.
With cash consideration of approximately 24m paid upon close and the potential to obtain additional performance-based consideration contingent upon 2012 and 2013 financial results, Matcon is expected to be